PIONEER: a phase III randomized trial of paclitaxel poliglumex versus paclitaxel in chemotherapy-naive women with advanced-stage non-small-cell lung cancer and performance status of 2.
Albain
Kathy S
KS
Loyola University, Chicago Medical Center, Maywood, IL 60153, USA. kalbain@lumc.edu
Belani
Chandra P
CP
Bonomi
Philip
P
O'Byrne
Kenneth J
KJ
Schiller
Joan H
JH
Socinski
Mark
M
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D017326:Clinical Trials, Phase III as Topic; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D017239:Paclitaxel / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D018579:Patient Selection; D011099:Polyglutamic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D016387:Women's Health
D000970:Antineoplastic Agents; D011099:Polyglutamic Acid; D017239:Paclitaxel; C509139:paclitaxel poliglumex